PA

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lukas M et al. – In the uncontrolled trial, administration of exogenous AP enzyme daily over a 7–day course to patients with UC was associated with short–term improvement in disease activity scores, with clinical effects being observed within 21 days and associated with reductions in C–reactive protein and stool calprotectin. AP enzyme treatment was well tolerated and nonimmunogenic.


   

Today in Gastroenterology...keeping you current

Pregnancy and Inflammatory Bowel Disease
Gastroenterology Clinics of North America, 11/16/09

Novel Diagnostic and Prognostic Modalities in Inflammatory Bowel Disease
Gastroenterology Clinics of North America, 11/17/09

Management of acute appendicitis: an imaging strategy in children
Pediatric Surgery International, 10/27/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address